FDA Brief

Warning letters Drugs

FDA warning letter to

Keta Med Lab / www.ketamedlab.com

High riskIssued Jun 23Posted Jul 7Center for Drug Evaluation and Research (CDER)

Keta Med Lab's website sold unapproved, misbranded ketamine liquid, troches and nasal spray to U.S. consumers without prescriptions, FDA says.

What happened

FDA reviewed the website www.ketamedlab.com on February 26, 2026 (FDA Establishment Identifier 3043543982). The agency found ketamine liquid, ketamine troches and an esketamine nasal spray offered for sale with claims that they treat depression or are used for anesthesia, none of them covered by an FDA-approved drug application. The site also offered these prescription drugs without requiring a prescription.

What FDA found

  1. The website sold ketamine drugs that have no FDA-approved application.

    FD&C Act sections 301(d) and 505(a) (21 U.S.C. 331(d), 355(a))
  2. The labeling did not carry adequate directions for use, and as prescription drugs for conditions a layperson cannot self-treat, such directions cannot be written.

    FD&C Act section 502(f)(1) (21 U.S.C. 352(f)(1)); 21 CFR 201.115(a)
  3. The website offered prescription drugs for sale without requiring a prescription.

    FD&C Act sections 503(b)(1) and 301(k) (21 U.S.C. 353(b)(1), 331(k))
  4. Website claims that the products are used for anesthesia and to treat depression show they are drugs intended for human use.

    FD&C Act section 201(g) (21 U.S.C. 321(g)); 21 CFR 201.128
  5. The nasal spray is sold outside the restricted safety program (REMS) that FDA requires for the approved esketamine nasal spray, which must be given in certified settings with two hours of monitoring.

What FDA wants

FDA tells the company to stop offering any unapproved and misbranded drugs for sale to U.S. consumers right away. It must send a written response within 15 business days describing the corrections made, how recurrence will be prevented, and supporting documents, citing reference MARCS-CMS 725154.

Who should pay attention

  • online sellers and telehealth companies offering ketamine products
  • clinics and compounding pharmacies marketing ketamine for depression
  • payment processors and platforms hosting websites that sell prescription drugs

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk